DLBCL: Clinical Trials

1 trial for DLBCL, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 enrolling by invitation. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Enrolling by invitation 1

Follow DLBCL: new trials by email Literature Review of DLBCL trials Research Report on DLBCL

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells
AUTO CAR T cell therapy - Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy, Multiple Myeloma
Phase 2Enrolling by invitationAutolus Limited5002018-08-022026-09-22

Narrower conditions

Lymphoma, T-Cell (1)  ·  Multiple Myeloma (1)

Broader conditions

Blood Protein Disorders (1)  ·  Cardiovascular Diseases (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hemorrhagic Disorders (1)  ·  Hemostatic Disorders (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Plasma Cell (1)

Sponsors

Autolus Limited (1)

Countries

Spain (1)  ·  United Kingdom (1)  ·  United States (1)